Related references
Note: Only part of the references are listed.Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases
Andrew Chang et al.
CELL (2022)
Age-dependent formation of TMEM106B amyloid filaments in human brains
Manuel Schweighauser et al.
NATURE (2022)
Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43
Yi Xiao Jiang et al.
NATURE (2022)
TMEM106B deficiency impairs cerebellar myelination and synaptic integrity with Purkinje cell loss
Tuancheng Feng et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2022)
Identification of TMEM106B amyloid fibrils provides an updated view of TMEM106B biology in health and disease
Jolien Perneel et al.
ACTA NEUROPATHOLOGICA (2022)
Aged Tmem106b knockout mice display gait deficits in coincidence with Purkinje cell loss and only limited signs of non-motor dysfunction
Stijn Stroobants et al.
BRAIN PATHOLOGY (2021)
Physiological and pathological functions of TMEM106B: a gene associated with brain aging and multiple brain disorders
Tuancheng Feng et al.
ACTA NEUROPATHOLOGICA (2021)
A novel temporal-predominant neuro-astroglial tauopathy associated with TMEM106B gene polymorphism in FTLD/ALS-TDP
Jorge J. Llibre-Guerra et al.
BRAIN PATHOLOGY (2021)
Loss of Tmem106b leads to cerebellum Purkinje cell death and motor deficits
Rosa Rademakers et al.
BRAIN PATHOLOGY (2021)
Analysis of genes (TMEM106B, GRN, ABCC9, KCNMB2, and APOE) implicated in risk for LATE-NC and hippocampal sclerosis provides pathogenetic insights: a retrospective genetic association study
Adam J. Dugan et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)
The TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportion
Zeran Li et al.
ACTA NEUROPATHOLOGICA (2020)
Loss ofTMEM106B andPGRNleads to severe lysosomal abnormalities and neurodegeneration in mice
Tuancheng Feng et al.
EMBO REPORTS (2020)
Loss of TMEM106B leads to myelination deficits: implications for frontotemporal dementia treatment strategies
Xiaolai Zhou et al.
BRAIN (2020)
A role of the frontotemporal lobar degeneration risk factor TMEM106B in myelination
Tuancheng Feng et al.
BRAIN (2020)
TMEM106B Effect on cognition in Parkinson disease and frontotemporal dementia
Thomas F. Tropea et al.
ANNALS OF NEUROLOGY (2019)
The TMEM106B risk allele is associated with lower cortical volumes in a clinically diagnosed frontotemporal dementia cohort
Sophie R. Harding et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Differential Aging Analysis in Human Cerebral Cortex Identifies Variants in TMEM106B and GRN that Regulate Aging Phenotypes
Herve Rhinn et al.
CELL SYSTEMS (2017)
A recurrent de novo mutation in TMEM106B causes hypomyelinating leukodystrophy
Cas Simons et al.
BRAIN (2017)
A Dementia-Associated Risk Variant near TMEM106B Alters Chromatin Architecture and Gene Expression
Michael D. Gallagher et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2017)
What we know about TMEM106B in neurodegeneration
Alexandra M. Nicholson et al.
ACTA NEUROPATHOLOGICA (2016)
Reassessment of Risk Genotypes (GRN, TMEM106B, and ABCC9 Variants) Associated With Hippocampal Sclerosis of Aging Pathology
Peter T. Nelson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2015)
TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions
Michael D. Gallagher et al.
ACTA NEUROPATHOLOGICA (2014)
TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia
Marka van Blitterswijk et al.
ACTA NEUROPATHOLOGICA (2014)
TMEM106B Influences Volume of Left-Sided Temporal Lobe and Interhemispheric Structures in the General Population
Hieab H. H. Adams et al.
BIOLOGICAL PSYCHIATRY (2014)
Regulated Intramembrane Proteolysis of the Frontotemporal Lobar Degeneration Risk Factor, TMEM106B, by Signal Peptide Peptidase-like 2a (SPPL2a)
Owen A. Brady et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
TMEM106B expression is reduced in Alzheimer's disease brains
Jun-ichi Satoh et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia
Alexandra M. Nicholson et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain
Johanna I. Busch et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2013)
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach
Thomas J. Montine et al.
ACTA NEUROPATHOLOGICA (2012)
Membrane Orientation and Subcellular Localization of Transmembrane Protein 106B (TMEM106B), a Major Risk Factor for Frontotemporal Lobar Degeneration
Christina M. Lang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
TMEM106B, the Risk Gene for Frontotemporal Dementia, Is Regulated by the microRNA-132/212 Cluster and Affects Progranulin Pathways
Alice S. Chen-Plotkin et al.
JOURNAL OF NEUROSCIENCE (2012)
TMEM106B RISK VARIANT IS IMPLICATED IN THE PATHOLOGIC PRESENTATION OF ALZHEIMER DISEASE
Nicola J. Rutherford et al.
NEUROLOGY (2012)
Risk genotypes at TMEM106B are associated with cognitive impairment in amyotrophic lateral sclerosis
Ryan Vass et al.
ACTA NEUROPATHOLOGICA (2011)
A harmonized classification system for FTLD-TDP pathology
Ian R. A. Mackenzie et al.
ACTA NEUROPATHOLOGICA (2011)
TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers
N. Finch et al.
NEUROLOGY (2011)
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
Mariely DeJesus-Hernandez et al.
NEURON (2011)
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP43 inclusions
Vivianna M. Van Deerlin et al.
NATURE GENETICS (2010)
Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies
Manuela Neumann et al.
ACTA NEUROPATHOLOGICA (2009)
Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia
Rosa Rademakers et al.
HUMAN MOLECULAR GENETICS (2008)
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Matt Baker et al.
NATURE (2006)
Share Paper
